Table 1. Clinical and Laboratory Data of... | American Society of Hematology

Table 1.

Clinical and Laboratory Data of Patients With Hereditary Spherocytosis

Patients	Age	Hemoglobin	MCV	MCHC	Reticulocytes	Spectrin/band 3^*	2.1/band 3^†	Relative Protein Content
	(yr)	g/dL	FL	g/dL	×10⁹/L
I.1	58	13.4	87	32.9	416.5	1.28	0.25	78% Band 3
II.1	36	12.4	91	32.5	544.70	1.34	0.28	75% Band 3
II.2	32	12.7	87	33.3	543.12	1.26	0.25	79% Band 3
3^‡	38	14.7	85	35.0	137.80	1.42	0.30	70% Band 3
4^‡	32	14.5	92	32.1	98.20	1.26	0.26	79% Band 3
5^‡	20	13.7	78	35.6	59.28	1.00	0.14	70% Ankyrin

Patients	Age	Hemoglobin	MCV	MCHC	Reticulocytes	Spectrin/band 3^*	2.1/band 3^†	Relative Protein Content
	(yr)	g/dL	FL	g/dL	×10⁹/L
I.1	58	13.4	87	32.9	416.5	1.28	0.25	78% Band 3
II.1	36	12.4	91	32.5	544.70	1.34	0.28	75% Band 3
II.2	32	12.7	87	33.3	543.12	1.26	0.25	79% Band 3
3^‡	38	14.7	85	35.0	137.80	1.42	0.30	70% Band 3
4^‡	32	14.5	92	32.1	98.20	1.26	0.26	79% Band 3
5^‡	20	13.7	78	35.6	59.28	1.00	0.14	70% Ankyrin

Abbreviations: MCV, mean corpuscular volume; MCHC, mean corpuscular hemoglobin concentration.

Ratio of spectrin/band 3 in 30 normal controls: x̄ ± SD = 1.0 ± 0.07 (0.92 to 1.10).

Ratio of ankyrin (2.1)/band 3 in 30 normal controls: x̄ ± SD = 0.20 ± 0.02 (0.17 to 0.24).

Splenectomized.